Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN). (Q47817797)

From Wikidata

Jump to navigation Jump to search

scientific article published on 2 May 2012

Language	Label	Description	Also known as
English	Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).	scientific article published on 2 May 2012

Statements

scholarly article

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/22552863

Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN). (English)

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/22552863

circulatory system

1 reference

based on heuristic

inferred from title

author name string

Sherilyn K D Houle

1

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/22552863

Anderson W Chuck

2

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/22552863

Finlay A McAlister

3

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/22552863

Ross T Tsuyuki

4

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/22552863

language of work or name

0 references

publication date

2 May 2012

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/22552863

Pharmacotherapy

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/22552863

32

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/22552863

6

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/22552863

527-537

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/22552863

A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN).

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01097.X

21 January 2018

Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01097.X

21 January 2018

The symptom mitigation path of mobile community residents: community pharmacy's role

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01097.X

21 January 2018

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01097.X

21 January 2018

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01097.X

21 January 2018

Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01097.X

21 January 2018

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01097.X

21 January 2018

Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT).

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01097.X

21 January 2018

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01097.X

21 January 2018

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01097.X

21 January 2018

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01097.X

21 January 2018

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01097.X

21 January 2018

Clinical and economic outcomes of medication therapy management services: the Minnesota experience

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01097.X

21 January 2018

Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study)

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01097.X

21 January 2018

The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01097.X

21 January 2018

Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01097.X

21 January 2018

Deterioration of blood pressure control after discontinuation of a physician-pharmacist collaborative intervention

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01097.X

21 January 2018

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01097.X

21 January 2018

Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01097.X

21 January 2018

Physician-pharmacist comanagement of hypertension: a randomized, comparative trial

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01097.X

21 January 2018

Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01097.X

21 January 2018

Improving hypertension management through pharmacist prescribing; the rural Alberta clinical trial in optimizing hypertension (Rural RxACTION): trial design and methods

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01097.X

21 January 2018

Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01097.X

21 January 2018

Identifiers

10.1002/J.1875-9114.2012.01097.X

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/22552863

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/22552863

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47817797&oldid=1234879969"